Connect Biopharmaceuticals is a clinical-stage company that develops immune modulators for the treatment of autoimmune and inflammatory diseases.
Business Model:
Revenue: $0
Employees: 51-200
Address: 6 Beijing West Road
City: Taicang
State: jiangsu province
Zip: 214500
Country: CN
Connect Biopharmaceuticals is a clinical-stage company that develops immune modulators for the treatment of autoimmune and inflammatory diseases.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
3/18/2021
IPO Valuation:
$949M
Ticker Symbol:
CNTB
IPO Price:
$17/share
Amount Raised:
$191M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2021 | IPO | $191.3M |
|
1/2017 | Series A | 4 | $20M |
Cowin Capital Qiming Venture Partners Northern Light Venture Capital Lapam Capital Cowin Capital Qiming Venture Partners |
1/2019 | Series B | 4 | $55M |
Advantech Capital Cowin Capital Northern Light Venture Capital Qiming Venture Partners Advantech Capital Cowin Capital Northern Light Venture Capital Qiming Venture Partners |
11/2016 | Seed Round | 3 | $5M |
Anlongmed Fund Cowin Capital XinYue Equity |
8/2020 | Series C | 5 | $115M |
Boxer Capital HBM Healthcare Investments AG Lilly Asia Ventures Qiming Venture Partners RA Capital Management Boxer Capital HBM Healthcare Investments AG Lilly Asia Ventures Qiming Venture Partners RA Capital Management |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|